Tacrolimus-induced bone marrow suppression [6]

Lancet

Volumn 350, Issue 9079, 1997, Pages 714-715

  De La Serna Higuera, C ^a   Barcena Marugan R ^a   Aviles J ^a   Nuno J ^a   Cantalapiedra, A ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; TACROLIMUS; VINCRISTINE;

ADULT; ALCOHOL LIVER DISEASE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; CASE REPORT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0343554687     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63514-3     Document Type: Article

References (4)

1. Winkler M, Schulze F, Jost U, Ringe B, Pichlmayr R. Anaemia associated with FK-506 immunosuppression. Lancet 1993; 341: 1035-36.
2. Suzuki S, Osaka Y, Nakai Y, et al. Pure red cell aplasia induced by FK-506. Transplantation 1996; 61: 831-32.
3. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; i: 585-87.
4. Opela G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-16.